Genprex, Inc.

Genprex, Inc.

Genprex, Inc.

Genprex (NASDAQ :: GNPX) is a clinicalstage biopharmaceutical company developing revolutionary immunogene therapies for cancer.
Raised
$10M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$10,000,000
Post-IPO equity - 2018
Team Size
1–10
Employees
$10,000,000 Post-IPO equity
FinSMEs , PE HUB

Genprex Raises $10M in Private Placement

Health